HTGS26 is a prominent pharma tech conference highlighting advancements in R&D through agentic AI and digital endpoints.
Agentic AI refers to autonomous AI systems capable of independent decision-making to accelerate drug discovery and development.
Digital endpoints leverage real-world data and sensors for more efficient, patient-centric clinical trials.
The event features keynotes on how these technologies reduce R&D timelines and costs by up to 30-50%.
Recent sessions (early March 2026) showcased case studies from leading biopharma companies implementing these innovations.
Organized by HTG, it draws 5,000+ attendees focusing on transforming the 'D' in R&D.